未登录

A

Ana M. Tari

university of texas system

H指数:32

被引数:3,174

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells

ONCOLOGY REPORTS

IF3.9

2013-06-1911

OAAI

Cyclooxygenase-2 (COX-2) utilizes Jun N-terminal kinases to induce invasion but not tamoxifen resistance in MCF-7 breast cancer cells

CANCER RESEARCH

IF16.6

2011-04-010

PRE

Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 p27 Phosphorylation in Epidermal Growth Factor Receptor-Expressing Breast Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2010-11-0918

OAAI

Pharmacokinetics, tissue distribution, and safety of P-ethoxy oligonucleotides incorporated in liposomes

JOURNAL OF LIPOSOME RESEARCH

IF4.3

2008-09-2813

PREAI

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells

小干扰RNA沉默Bcl-2表达诱导MCF-7乳腺癌细胞自噬性死亡

IF14.3

2008-05-22240

OAAI

Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma

CANCER RESEARCH

IF16.6

2007-11-15210

OAAI

Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma

CLINICAL CANCER RESEARCH

IF10.2

2007-11-1565

PREAI

Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells

BREAST CANCER RESEARCH

IF5.6

2007-07-055

OAAI

Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl) retinamide inhibitory effects in breast cancer cells

LABORATORY INVESTIGATION

IF4.2

2005-11-0123

PREAI

N-(4-hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells

IF2.9

2005-09-3047

OAAI

Mechanism of action of a novel combi-triazene engineered to possess a polar functional group on the alkylating moiety: Evidence for enhancement of potency

BIOCHEMICAL PHARMACOLOGY

IF5.6

2005-08-0132

PREAI

N-(4-hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells

IF2.9

2005-02-0332

OAAI

HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells

IF7.3

2005-01-1773

OAAI

The combi-targeting concept: Dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2004-12-0133

PREAI

KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2004-12-0133

PREAI

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line

BRITISH JOURNAL OF CANCER

IF6.8

2004-09-0722

OAAI

Multiple mechanisms of action of ZR2002 in human breast cancer cells: A novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2004-06-2329

PREAI

Cyclooxygenase-2 is essential for HER2/neu to suppress N-(4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells

CANCER RESEARCH

IF16.6

2004-02-1849

OAAI

The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2003-06-01156

OAAI

Par-4 transcriptionally regulates bcl-2 through a WT1-binding site on the bcl-2 promoter

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2003-05-01109

OAAI